Detalles de la búsqueda
1.
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Br J Cancer
; 118(10): 1296-1301, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29695768
2.
Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum Concentrations.
Ther Drug Monit
; 40(5): 596-601, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29847460
3.
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
Cancer Treat Rev
; 122: 102662, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043396
4.
The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy.
Biomed Pharmacother
; 156: 113839, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228374
5.
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Eur J Cancer
; 174: 113-120, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35988409
6.
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34088739
7.
Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients.
Thyroid
; 30(7): 966-973, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32151195
8.
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32461348
9.
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
J Immunother Cancer
; 8(2)2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33427690
10.
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.
Eur J Cancer
; 109: 12-20, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30654225
11.
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.
J Immunother Cancer
; 7(1): 192, 2019 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324223
12.
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
J Immunother Cancer
; 7(1): 149, 2019 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31176366
Resultados
1 -
12
de 12
1
Próxima >
>>